---
intellectual_kind: research_action_pack
parent_initiative: INIT-OPENCLAW_AKOS-97
related_initiatives: [96, 93, 94, 95, 88, 75, 86, 17, 67]
authored: 2026-06-12
last_review: 2026-06-12
status: active
role_owner: Holistik Researcher
co_owner_roles: [System Owner, PMO, CDO]
language: en
discipline: RESEARCH_ACTION_DISCIPLINE.md (D-IH-86-FF)
source_ledger: source-ledger.csv
control_confidence_level: Euclid
---

# Research-action pack — Infonomics / Holistika data economics

> **Control layer** for the Infonomics research action per
> [`RESEARCH_ACTION_DISCIPLINE.md`](../../../references/hlk/v3.0/Research/Methodology/canonicals/RESEARCH_ACTION_DISCIPLINE.md)
> and [`akos-research-action.mdc`](../../../../.cursor/rules/akos-research-action.mdc) RULE 1 (mandatory source ledger).

## 1. Named downstream decision (decision first, research second)

Every source in [`source-ledger.csv`](source-ledger.csv) rates against **one primary decision**:

> **D-INF-ECON — Before minting enterprise Infonomics doctrine (P6), what economic model should Holistika adopt for information and data assets across O5-1 areas — and which existing canonicals amend vs net-new discipline?**

Sub-questions map to `decision_use` tags:

| Tag | Sub-question |
|:---|:---|
| `def-valuation` | How do we **value** information/data assets (cost, benefit, quality ROI)? |
| `def-ownership` | Who **owns** economic outcomes per area/prong (RACI + registers)? |
| `def-incentives` | What **incentives** align build/maintain/spend decisions? |
| `def-overlap` | How does I96 Research Center economics **overlap** without duplicating Track D? |
| `def-vault` | **Mint** cross-area discipline vs **amend** Data/FINOPS/RevOps only? |

## 2. Ratified ledger bar (D-IH-97-B)

| Pool | Target | Opens |
|:---|:---|:---|
| Internal CORPINT | ≥300 rows | P2 |
| External OSINT | ≥500 rows | P3 |
| **Total** | **≥800 rows** | P3 close |
| Skeptic rows | ≥2 per load-bearing prong | P3 |

## 3. Eight-stage loop application

| Stage | Artifact in this pack | Status |
|:---|:---|:---|
| 1 Ingest | [`source-ledger.csv`](source-ledger.csv) | ✅ **800 rows** (300 CORPINT + 500 OSINT) |
| 2 Rate | per-row reliability + external credibility + Safe/Euclid/Keter | gated on ingest |
| 3 Rank | `baseline-state-2026-06-12.md` + prong relevance | P2 |
| 4 Synthesize | 14 × `prong-bl-*.md` + master syntheses | ✅ P4 |
| 5 Govern | D-IH-97-C/D inline-ratify; overlap tracker | ✅ P5 **closed 2026-06-13** |
| 6 Implement | Vault tranches P6a→P6b | **scheduled** — DCAM axis then doctrine |
| 7 Test | `validate_research_action.py` + UAT + HLK if canonical | P3/P6/P7 |
| 8 Iterate | Disposition per cluster in master synthesis | P7–P8 |

## 4. Folder shape (target end state)

```
docs/wip/intelligence/infonomics-holistika-data-economics-2026-06-12/
├── README.md
├── charter.md
├── research-action-pack.md              (this file)
├── source-ledger-prong-ssot-2026-06-12.md
├── source-ledger.csv
├── baseline-state-2026-06-12.md         (P2 ✅)
├── prong-bl-*.md                         (P4 ×14)
├── master-synthesis.md                  (P4)
├── master-synthesis-hxpestel.md         (P4)
├── hxpestal-intent-tracking-2026-06-12.md (P4)
└── implementation-spec-2026-06-12.md    (P6)
```

## 5. Verification

```powershell
py scripts/validate_research_action.py --self-test
py scripts/validate_research_action.py --source-ledger docs/wip/intelligence/infonomics-holistika-data-economics-2026-06-12/source-ledger.csv
```

## 6. Cross-references

- Initiative roadmap: [`../../planning/97-infonomics-holistika-data-economics/master-roadmap.md`](../../planning/97-infonomics-holistika-data-economics/master-roadmap.md)
- Overlap tracker: [`../../planning/_trackers/i96-i97-infonomics-scope-overlap-tracker.md`](../../planning/_trackers/i96-i97-infonomics-scope-overlap-tracker.md)
- Carryover index: CO-97-001..004 in [`../../planning/_trackers/carryover-posture-index.md`](../../planning/_trackers/carryover-posture-index.md)
- Operator steering: [`../../planning/OPERATOR_STEERING_AND_CARRYOVER.md`](../../planning/OPERATOR_STEERING_AND_CARRYOVER.md)
